These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30167941)

  • 21. Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition.
    Lan TH; Xu ZW; Wang Z; Wu YL; Wu WK; Tan HM
    Biochem Pharmacol; 2011 Jul; 82(2):148-55. PubMed ID: 21515242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginsenoside Rb1 Protects the Brain from Damage Induced by Epileptic Seizure via Nrf2/ARE Signaling.
    Shi Y; Miao W; Teng J; Zhang L
    Cell Physiol Biochem; 2018; 45(1):212-225. PubMed ID: 29357320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of ginsenoside Rg1 on the expressions of p-eRK1/2 and p-JNK in local cerebral ischemia/reperfusion injury rats].
    Wang QY; Liu F; Wu FJ; Li JL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):229-34. PubMed ID: 23646480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
    Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
    J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model.
    Yang T; Miao Y; Zhang T; Mu N; Ruan L; Duan J; Zhu Y; Zhang R
    J Pharm Pharmacol; 2018 Jun; 70(6):830-838. PubMed ID: 29574918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-29a-3p Regulates SH-SY5Y Cell Proliferation and Neurite Growth through Interaction with PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Gao W; Yang H; Huang W; Yang Y; Li D; Wei L
    Dis Markers; 2022; 2022():8151161. PubMed ID: 35958280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-3-n-Butylphthalide Activates Akt/mTOR Signaling, Inhibits Neuronal Apoptosis and Autophagy and Improves Cognitive Impairment in Mice with Repeated Cerebral Ischemia-Reperfusion Injury.
    Xu J; Huai Y; Meng N; Dong Y; Liu Z; Qi Q; Hu M; Fan M; Jin W; Lv P
    Neurochem Res; 2017 Oct; 42(10):2968-2981. PubMed ID: 28620824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolvin D1 prevents cadmium chloride-induced memory loss and hippocampal damage in rats by activation/upregulation of PTEN-induced suppression of PI3K/Akt/mTOR signaling pathway.
    Shati AA; El-Kott AF; Alkhateeb MA
    Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):275-290. PubMed ID: 34570918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
    Li Q; Shen L; Wang Z; Jiang HP; Liu LX
    Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginsenoside Rb1 eliminates HIV-1 (D3)-transduced cytoprotective human macrophages by inhibiting the AKT pathway.
    Jeong JJ; Kim B; Kim DH
    J Med Food; 2014 Aug; 17(8):849-54. PubMed ID: 24983400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury.
    Zhang QG; Wu DN; Han D; Zhang GY
    FEBS Lett; 2007 Feb; 581(3):495-505. PubMed ID: 17239858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus.
    Wu DN; Pei DS; Wang Q; Zhang GY
    Neurosci Lett; 2006 Aug; 404(1-2):98-102. PubMed ID: 16762504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic-Ischemic Brain Injury.
    Tu L; Wang Y; Chen D; Xiang P; Shen J; Li Y; Wang S
    Neurochem Res; 2018 Jun; 43(6):1210-1226. PubMed ID: 29696512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling.
    Liu L; Hu X; Cai GY; Lv Y; Zhuo L; Gao JJ; Cui SY; Feng Z; Fu B; Chen XM
    Nephrol Dial Transplant; 2012 Jan; 27(1):90-100. PubMed ID: 21633095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation.
    Diez H; Benitez MJ; Fernandez S; Torres-Aleman I; Garrido JJ; Wandosell F
    Biochim Biophys Acta; 2016 Nov; 1863(11):2574-2583. PubMed ID: 27421985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginsenoside Rb1 promotes the growth of mink hair follicle via PI3K/AKT/GSK-3β signaling pathway.
    Zhang H; Su Y; Wang J; Gao Y; Yang F; Li G; Shi Q
    Life Sci; 2019 Jul; 229():210-218. PubMed ID: 31102746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro studies of Raf-CREB, Akt-CREB, and CaMK II -CREB signal transduction pathway regulated by ginsenosides Rb1, Rg1 and Re].
    Wang TT; Dong XZ; Liu WW; Chen YH; Liu P
    Zhongguo Zhong Yao Za Zhi; 2014 Jun; 39(11):2065-70. PubMed ID: 25272844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
    Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
    Lu M; Fei Z; Zhang G
    Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xanthohumol Inhibits TGF-β1-Induced Cardiac Fibroblasts Activation via Mediating PTEN/Akt/mTOR Signaling Pathway.
    Jiang C; Xie N; Sun T; Ma W; Zhang B; Li W
    Drug Des Devel Ther; 2020; 14():5431-5439. PubMed ID: 33324040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.